Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)

Noam Ponde, Ian Bradbury, Matteo Lambertini, Michael Ewer, Christine Campbell, Helene Ameels, Dimitrios Zardavas, Serena Di Cosimo, José Baselga, Jens Huober, Miguel Izquierdo, Debora Fumagalli, Ivana Bozovic-Spasojevic, Marion Maetens, Nadia Harbeck, Lajos Pusztai, Michael Berghorn, Young-Hyuck Im, Manuel Ruiz Borrego, Dar-Ren Chen, Richard Rodeheffer, Martine Piccart, Thomas Suter, Evandro de Azambuja

Open source

DOI: 10.1007/s10549-017-4628-3
Published: 2017-12-27
Container: Breast Cancer Research and Treatment
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10549-017-4628-3,
  title = {Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)},
  author = {Noam Ponde and Ian Bradbury and Matteo Lambertini and Michael Ewer and Christine Campbell and Helene Ameels and Dimitrios Zardavas and Serena Di Cosimo and José Baselga and Jens Huober and Miguel Izquierdo and Debora Fumagalli and Ivana Bozovic-Spasojevic and Marion Maetens and Nadia Harbeck and Lajos Pusztai and Michael Berghorn and Young-Hyuck Im and Manuel Ruiz Borrego and Dar-Ren Chen and Richard Rodeheffer and Martine Piccart and Thomas Suter and Evandro de Azambuja},
  year = {2017},
  journal = {Breast Cancer Research and Treatment},
  doi = {10.1007/s10549-017-4628-3},
  url = {https://doi.org/10.1007/s10549-017-4628-3}
}

RIS

TY  - JOUR
TI  - Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)
AU  - Noam Ponde
AU  - Ian Bradbury
AU  - Matteo Lambertini
AU  - Michael Ewer
AU  - Christine Campbell
AU  - Helene Ameels
AU  - Dimitrios Zardavas
AU  - Serena Di Cosimo
AU  - José Baselga
AU  - Jens Huober
AU  - Miguel Izquierdo
AU  - Debora Fumagalli
AU  - Ivana Bozovic-Spasojevic
AU  - Marion Maetens
AU  - Nadia Harbeck
AU  - Lajos Pusztai
AU  - Michael Berghorn
AU  - Young-Hyuck Im
AU  - Manuel Ruiz Borrego
AU  - Dar-Ren Chen
AU  - Richard Rodeheffer
AU  - Martine Piccart
AU  - Thomas Suter
AU  - Evandro de Azambuja
PY  - 2017
JO  - Breast Cancer Research and Treatment
DO  - 10.1007/s10549-017-4628-3
UR  - https://doi.org/10.1007/s10549-017-4628-3
ER  -

APA

Ponde, N., Bradbury, I., Lambertini, M., Ewer, M., Campbell, C., Ameels, H., Zardavas, D., Cosimo, S. D., Baselga, J., Huober, J., Izquierdo, M., Fumagalli, D., Bozovic-Spasojevic, I., Maetens, M., Harbeck, N., Pusztai, L., Berghorn, M., Im, Y., Borrego, M. R., Chen, D., Rodeheffer, R., Piccart, M., Suter, T., & Azambuja, E. D. (2017). Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06). Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-017-4628-3

Source records

crossref · retrieved 2026-09-25T11:44:20.607Z